Drug cos see no biz value in raw material production

•Download as PPTX, PDF•

0 likes•180 views

Other Mother

Health & Medicine

Local industry supports import of many raw materials that are about a
third cheaper than domestically-produced chemicals

The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.

MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf

Jim Jacob Roy

Recently uploaded

New Drug Discovery and Development .....

NEHA GUPTA

MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf

Jim Jacob Roy

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...

Catherine Liao

Cervical & Brachial Plexus By Dr. RIG.pptx

Dr. Rabia Inam Gandapore

Ophthalmology Clinical Tests for OSCE exam

KafrELShiekh University

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...

VarunMahajani

micro teaching on communication m.sc nursing.pdf

Anurag Sharma

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

bkling

Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.

Desidustat the rise of a new dawn - role in treatment of ckd anemia

Dr. Lalit Agarwal

LAMPIRAN A - research proposal (oral CANCER).docx

Azreen Aj

The History of Diagnostic Medical imaging

Yahye Mohamed

ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx

Bright Chipili

THOA 2.ppt Human Organ Transplantation Act

DrSathishMS1

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Dr Jeenal Mistry

Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol that is rapidly distributed in the body and brain. Ethanol alters many neurochemical systems and has rewarding and addictive properties. It is the oldest recreational drug and likely contributes to more morbidity, mortality, and public health costs than all illicit drugs combined. The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) integrates alcohol abuse and alcohol dependence into a single disorder called alcohol use disorder (AUD), with mild, moderate, and severe subclassifications (American Psychiatric Association, 2013). In the DSM-5, all types of substance abuse and dependence have been combined into a single substance use disorder (SUD) on a continuum from mild to severe. A diagnosis of AUD requires that at least two of the 11 DSM-5 behaviors be present within a 12-month period (mild AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria). The four main behavioral effects of AUD are impaired control over drinking, negative social consequences, risky use, and altered physiological effects (tolerance, withdrawal). This chapter presents an overview of the prevalence and harmful consequences of AUD in the U.S., the systemic nature of the disease, neurocircuitry and stages of AUD, comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and pharmacotherapies for AUD.

basicmodesofventilation2022-220313203758.pdf

aljamhori teaching hospital

Couples presenting to the infertility clinic- Do they really have infertility...

Sujoy Dasgupta

Non-Invasive assessment of arterial stiffness in advanced heart failure patie...

Catherine Liao

Fundamental of Radiobiology -SABBU.pptx

Sabbu Khatoon

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Savita Shen $i11

Recently uploaded (20)

New Drug Discovery and Development .....

MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...

Cervical & Brachial Plexus By Dr. RIG.pptx

Ophthalmology Clinical Tests for OSCE exam

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...

micro teaching on communication m.sc nursing.pdf

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

Desidustat the rise of a new dawn - role in treatment of ckd anemia

LAMPIRAN A - research proposal (oral CANCER).docx

The History of Diagnostic Medical imaging

ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx

THOA 2.ppt Human Organ Transplantation Act

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

basicmodesofventilation2022-220313203758.pdf

Couples presenting to the infertility clinic- Do they really have infertility...

Non-Invasive assessment of arterial stiffness in advanced heart failure patie...

Fundamental of Radiobiology -SABBU.pptx

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls